STOCK TITAN

Agronomics Invests US$2M in Liberation Labs

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Agronomics (LSE:ANIC) has invested US$2 million in Liberation Labs Holdings Inc.'s US$3.5 million fundraise via a Secured Promissory Note. The note pays 10% interest annually and matures on October 10, 2027. Additionally, Liberation Labs received a US$1.39 million award from the US Department of Defense for a feasibility study on adding a 4 million litre biomanufacturing facility.

Liberation Labs has signed letters of intent with potential customers representing over 200% of available capacity for its Launch Facility's first years of operations. Agronomics has now invested a total of US$19.6 million in Liberation Labs, holding 37.5% on a fully diluted basis. The company's position in Liberation Labs represents approximately 15.9% of Agronomics' last stated Net Asset Value.

Agronomics (LSE:ANIC) ha investito 2 milioni di dollari USA nel fundraising di 3,5 milioni di dollari USA di Liberation Labs Holdings Inc. tramite una Nota di Prestito Garantita. La nota paga un interesse del 10% annuale e scade il 10 ottobre 2027. Inoltre, Liberation Labs ha ricevuto un premio di 1,39 milioni di dollari USA dal Dipartimento della Difesa degli Stati Uniti per uno studio di fattibilità su un impianto di biomanifattura da 4 milioni di litri.

Liberation Labs ha firmato lettere di intenti con clienti potenziali che rappresentano oltre il 200% della capacità disponibile per i primi anni di operazione del suo Stabilimento di Lancio. Agronomics ha ora investito un totale di 19,6 milioni di dollari USA in Liberation Labs, detenendo il 37,5% su una base completamente diluita. La posizione dell'azienda in Liberation Labs rappresenta circa il 15,9% dell'ultimo valore netto degli attivi dichiarato da Agronomics.

Agronomics (LSE:ANIC) ha invertido 2 millones de dólares EE. UU. en la recaudación de fondos de 3.5 millones de dólares EE. UU. de Liberation Labs Holdings Inc. a través de una Nota Promisoria Asegurada. La nota paga un interés del 10% anual y vence el 10 de octubre de 2027. Además, Liberation Labs recibió un premio de 1.39 millones de dólares EE. UU. del Departamento de Defensa de EE. UU. para un estudio de viabilidad sobre la adición de una instalación de biomanufactura de 4 millones de litros.

Liberation Labs ha firmado cartas de intención con clientes potenciales que representan más del 200% de la capacidad disponible para los primeros años de operación de su Instalación de Lanzamiento. Agronomics ha invertido ahora un total de 19.6 millones de dólares EE. UU. en Liberation Labs, manteniendo el 37.5% sobre una base completamente diluida. La posición de la empresa en Liberation Labs representa aproximadamente el 15.9% del último Valor Neto de Activos declarado por Agronomics.

Agronomics (LSE:ANIC)는 Liberation Labs Holdings Inc.의 350만 달러 규모의 자금 조달에 200만 달러를 투자했습니다. 이는 담보 약속어음(Secured Promissory Note)을 통해 이루어졌습니다. 이 약속어음은 연간 10%의 이자를 지급하며, 만기는 2027년 10월 10일입니다. 또한, Liberation Labs는 4백만 리터의 생물 제조 시설 추가에 대한 타당성 연구를 위해 미국 국방부로부터 139만 달러의 지원금을 받았습니다.

Liberation Labs는 운영 초기 몇 년 동안 사용할 수 있는 용량의 200% 이상을 나타내는 잠재 고객과의 의향서에 서명했습니다. Agronomics는 이제 Liberation Labs에 총 1960만 달러를 투자했으며, 완전 희석 기준으로 37.5%를 보유하고 있습니다. Liberation Labs에서의 회사의 지분은 Agronomics의 마지막 공시된 순자산 가치의 약 15.9%를 차지합니다.

Agronomics (LSE:ANIC) a investi 2 millions de dollars US dans la levée de fonds de 3,5 millions de dollars US de Liberation Labs Holdings Inc. via une Note de Prêt Securisée. La note paie un intérêt de 10% par an et arrive à échéance le 10 octobre 2027. De plus, Liberation Labs a reçu une prime de 1,39 million de dollars US du Département de la Défense des États-Unis pour une étude de faisabilité sur l'ajout d'une installation de biomanufacture de 4 millions de litres.

Liberation Labs a signé des lettres d'intention avec des clients potentiels représentant plus de 200% de la capacité disponible pour les premières années d'exploitation de son Établissement de Lancement. Agronomics a maintenant investi un total de 19,6 millions de dollars US dans Liberation Labs, détenant 37,5% sur une base totalement diluée. La position de l'entreprise dans Liberation Labs représente environ 15,9% de la dernière valeur nette d'actifs déclarée par Agronomics.

Agronomics (LSE:ANIC) hat 2 Millionen US-Dollar in die 3,5 Millionen US-Dollar umfassende Kapitalbeschaffung von Liberation Labs Holdings Inc. über eine gesicherte Schuldverschreibung investiert. Die Schuldverschreibung zahlt jährlich 10% Zinsen und läuft am 10. Oktober 2027 aus. Darüber hinaus erhielt Liberation Labs eine 1,39 Millionen US-Dollar hohe Auszeichnung vom US-Verteidigungsministerium für eine Machbarkeitsstudie zur Hinzufügung einer Bioproduktionsanlage mit einem Volumen von 4 Millionen Litern.

Liberation Labs hat mit potenziellen Kunden Absichtserklärungen unterzeichnet, die über 200% der verfügbaren Kapazität für die ersten Jahre des Betriebs seiner Startanlage repräsentieren. Agronomics hat nun insgesamt 19,6 Millionen US-Dollar in Liberation Labs investiert und hält 37,5% auf voll verwässerter Basis. Die Position des Unternehmens in Liberation Labs repräsentiert etwa 15,9% des zuletzt verfügbaren Nettovermögenswerts von Agronomics.

Positive
  • Agronomics invested US$2 million in Liberation Labs, strengthening its position in cellular agriculture
  • Liberation Labs received a US$1.39 million award from the US Department of Defense
  • Liberation Labs has signed letters of intent representing over 200% of available capacity for its Launch Facility
  • Agronomics now holds 37.5% of Liberation Labs on a fully diluted basis
Negative
  • Liberation Labs is an early-stage company with no revenues
  • Liberation Labs has operating costs of approximately US$0.4 million per month
  • Liberation Labs has liabilities of US$43.8 million as of June 30, 2024

Agronomics invests US$ 2 million in Liberation Labs US$ 3.5 million fundraise and US Department of Defense US$ 1.39 million award

DOUGLAS, ISLE OF MAN / ACCESSWIRE / October 15, 2024 / AgronomicsLimited (LSE:ANIC), a leading listed company in the field of cellular agriculture, reports that portfolio company Liberation Labs Holdings Inc. ("Liberation Labs") has raised a further US$ 3.5 million via a Secured Promissory Note ("Note"), including a US$ 2.0 million subscription from Agronomics using its own cash resources. The Note pays interest at 10% per annum and matures on 10 October 2027. Liberation Labs has also received a US$ 1.39 million award under the US Department of Defense's ("DoD") Distributed Bioindustrial Manufacturing Program.

The Note, a form of convertible debt, is for financing the continued construction of its facility in Richmond, Indiana in advance of Liberation Labs' intended Series A round (a "Qualified Financing") as set out in the 5 April 2024 announcement. The Notes will convert into the same instrument and terms as the Qualified Financing and are anticipated to raise a minimum of US$ 37.5 million through a combination of debt and equity.

Department of Defense Award
In addition, Liberation Labs has received a US$ 1.39 million award from the DoD to conduct a detailed feasibility study (engineering and market analysis) for the addition of a flexible-use, commercial-scale 4 million litre biomanufacturing facility adjacent to its Launch Facility.

The award is part of DoD's Distributed Bioindustrial Manufacturing Program, established by the White House's Executive Order 14081, "Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy." The programme aims to bolster America's bioeconomic strengths while helping the Department achieve advanced defense capabilities and supply chain resiliency.

Upon successful completion of the Prototype Assessment and Planning phase, Liberation Labs may be selected to proceed to the Prototype Build phase, which would provide up to US$ 100 million for building new facilities or expanding current facilities for bioindustrial manufacturing.

Agronomics' Executive Chair Jim Mellon commented:

"In 2020, McKinsey estimated that approximately 60% of all physical inputs of the global economy could be produced via biomanufacturing. The DoD's recent commitment to invest across fabrication, firepower, fitness, food and fuel, demonstrates the potential of a biomanufacturing ecosystem in which the benefits of more secure and reliable supply chains are delivered across industries.

In line with this, Liberation Labs' has made significant steps towards securing binding offtake agreements for its Launch Facility. The company now has signed letters of intent with potential customers representing well over 200% of the available capacity for the first few years of operations, demonstrating strong demand for "fit for purpose" biomanufacturing facilities across food, fuel, materials and pharmaceuticals."

Since the US$ 2.0 million subscription from Agronomics is considered a Substantial Transaction under AIM Rule 12, this announcement requires certain disclosures under Schedule Four. Liberation Labs is an early-stage company with no revenues and operating costs of approximately US$ 0.4 million per month, and total assets as at 30 June 2024 of approximately US$ 49.5 million and liabilities of US$ 43.8 million.

Including this Note, Agronomics has invested US$ 19.6 million in Liberation Labs which, subject to audit, is currently carried at a book value of £25.7 million. This funding round, however, will have no impact on the Liberation Labs current carrying value. The position represents approximately 15.9% of Agronomics' last stated Net Asset Value, including post-balance sheet date adjustments. Agronomics now holds 37.5% of Liberation Labs on a fully diluted basis.

The following have each subscribed US$ 0.5 million on identical terms to Agronomics: New Agrarian Company Limited, an affiliate of Agronomics; Galloway Limited; and Jim Mellon, Executive Chair of Agronomics, in his own name. Galloway Limited is indirectly wholly owned by Jim Mellon and Denham Eke is a director.

About Liberation Labs
Liberation Labs is commercializing precision fermentation with a global network of purpose-built manufacturing facilities that enable the next wave of biotechnology advancements to produce bio-based consumer products at scale. We combine modern technology with fit-for-purpose design to bring reliable and cost-effective solutions that meet customer demand across the world. More information is available at www.liberationlabs.com.

About Agronomics
Agronomics is a leading London-listed company focussing on investment opportunities within the field of cellular agriculture. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and improve food security for the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

For further information please contact:

Agronomics Limited

Beaumont Cornish Limited

Canaccord Genuity Limited

Cavendish Capital Markets Limited

Peterhouse Capital Limited

SEC Newgate

The Company

Nomad

Joint Broker

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Andrew Potts

Harry Pardoe

Alex Aylen (Head of Equities)

Giles Balleny

Michael Johnson

Charlie Combe

Lucy Williams

Charles Goodfellow

Bob Huxford

Anthony Hughes

+44 (0) 1624 639396

info@agronomics.im

+44 (0) 207 628 3396

+44 (0) 207 523 8000

+44 (0) 207 397 8900

+44 (0) 207 469 0936

agronomics@secnewgate.co.uk

Nominated Adviser
Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Agronomics Limited



View the original press release on accesswire.com

FAQ

How much did Agronomics (AGNMF) invest in Liberation Labs' recent fundraise?

Agronomics invested US$2 million in Liberation Labs' recent US$3.5 million fundraise via a Secured Promissory Note.

What is the interest rate and maturity date of the Secured Promissory Note issued by Liberation Labs?

The Secured Promissory Note issued by Liberation Labs pays 10% interest per annum and matures on October 10, 2027.

How much funding did Liberation Labs receive from the US Department of Defense?

Liberation Labs received a US$1.39 million award from the US Department of Defense for a feasibility study on adding a 4 million litre biomanufacturing facility.

What percentage of Liberation Labs does Agronomics (AGNMF) now hold?

Agronomics now holds 37.5% of Liberation Labs on a fully diluted basis.

AGRONOMICS LTD

OTC:AGNMF

AGNMF Rankings

AGNMF Latest News

AGNMF Stock Data

61.46M
827.24M
16.63%
9.93%
Asset Management
Financial Services
Link
United States of America
Ramsey